HomeCongratulations to Our 2024 Grand Prize and First Place Winners! NETrolyze, a novel immunotherapy for triple-negative breast cancer (TNBC), was named the $25,000 grand prize winner at a live finalist round held November 15 in New York. The first-in-class therapeutic injectable gel prevents the spread of TNBC, one of the most aggressive cancer types, enabling patients to avoid toxic chemotherapy an
{{#tags}}- {{label}}
{{/tags}}